Our data suggest that targeting just one impaired step in the cardioprotective signalling cascade is insufficient, possibly due to the additional age-diabetes-induced impairment in the cardioprotective signalling cascades downstream of eNOS. The gene discussed is NOS3; the disease is diabetes mellitus.